Success Metrics

Clinical Success Rate
70.2%

Based on 40 completed trials

Completion Rate
70%(40/57)
Active Trials
13(14%)
Results Posted
53%(21 trials)
Terminated
17(19%)

Phase Distribution

Ph phase_3
27
30%
Ph early_phase_1
2
2%
Ph phase_1
1
1%
Ph phase_2
19
21%
Ph not_applicable
9
10%
Ph phase_4
25
27%

Phase Distribution

3

Early Stage

19

Mid Stage

52

Late Stage

Phase Distribution83 total trials
Early Phase 1First-in-human
2(2.4%)
Phase 1Safety & dosage
1(1.2%)
Phase 2Efficacy & side effects
19(22.9%)
Phase 3Large-scale testing
27(32.5%)
Phase 4Post-market surveillance
25(30.1%)
N/ANon-phased studies
9(10.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

67.8%

40 of 59 finished

Non-Completion Rate

32.2%

19 ended early

Currently Active

13

trials recruiting

Total Trials

91

all time

Status Distribution
Active(16)
Completed(40)
Terminated(19)
Other(16)

Detailed Status

Completed40
Terminated17
unknown16
Recruiting12
Not yet recruiting3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
91
Active
13
Success Rate
70.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (2.4%)
Phase 11 (1.2%)
Phase 219 (22.9%)
Phase 327 (32.5%)
Phase 425 (30.1%)
N/A9 (10.8%)

Trials by Status

active_not_recruiting11%
completed4044%
not_yet_recruiting33%
terminated1719%
unknown1618%
withdrawn22%
recruiting1213%

Recent Activity

Clinical Trials (91)

Showing 20 of 91 trialsScroll for more
NCT07168161Phase 3

BDB-001 Phase III Trial in ANCA-Associated Vasculitis

Recruiting
NCT07616154Phase 2

Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease

Recruiting
NCT07138898Phase 2

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

Recruiting
NCT03490539

Disease-Modifying Treatments for Myasthenia Gravis

Completed
NCT03414502Phase 3

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

Recruiting
NCT07352566Phase 4

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

Not Yet Recruiting
NCT07619898Phase 2

PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure

Not Yet Recruiting
NCT07271069

Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis

Recruiting
NCT04469842Early Phase 1

Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

Recruiting
NCT06476366Early Phase 1

Comparison of Efficacy of Methotrexate and Azathioprine in Patients With Chronic Actinic Dermatitis: A Randomized Controlled Trial

Completed
NCT02939573Phase 2

A Randomized Multicenter Study for Isolated Skin Vasculitis

Recruiting
NCT03164473Phase 3

Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.

Completed
NCT00748644Phase 3

Efficacy Study of Two Treatments in the Remission of Vasculitis

Completed
NCT04773392Phase 4

Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR

Terminated
NCT07044141Phase 1

Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo

Active Not Recruiting
NCT03681652

Post-Operative Crohn's Disease Outcome in Children

Recruiting
NCT02994927Phase 3

A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis

Completed
NCT00866684Phase 4

Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol

Terminated
NCT06213857Phase 2

Beneficial Effect of Silymarin in Ulcerative Colitis

Recruiting
NCT05349006Phase 3

Azathioprine in MOGAD

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
91